Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Khalid Umar Fakhri has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In vitro and in silico antifungal susceptibilities of thymol against Aspergillus flavus

    by Shabana Khatoon, Nafis Raj, Khalid Umar Fakhri, Sugandh Kumar, Nikhat Manzoor


  • Open Access

    The Dual Role of Dietary Phytochemicals in Oxidative Stress: Implications for Oncogenesis, Cancer Chemoprevention, and ncRNA Regulation

    by Khalid Umar Fakhri, Deepti Sharma, Homa Fatma, Durdana Yasin, Manzar Alam, Neha Sami, Farhan Jalees Ahmad, Anas Shamsi, Moshahid Alam Rizvi

    Oxidative stress (OS), resulting from an imbalance between reactive oxygen species (ROS) and the antioxidant defense system, plays a critical role in the initiation and progression of cancer. Recent research has highlighted the regulatory influence of non-coding RNAs (ncRNAs) on cancer initiation and development through the regulation of redox homeostasis and key signaling pathways, which makes them potential targets for anticancer therapy. The ncRNA–oxidative stress axis contributes to malignancy through DNA damage, altered signaling, and dysregulated molecular networks. Plant-derived dietary components and phytochemicals have garnered significant attention for their ability to restore ROS balance and modulate the ncRNA/OS axis, thereby inhibiting carcinogenesis and enhancing the efficacy of chemotherapy. To study the interplay between OS, ncRNAs, and the anticancer potential of plant-derived compounds, in this review, we conducted an extensive search of electronic databases to identify and analyze studies that explore the interwork between OS, ncRNAs, and the chemotherapeutic role of phytochemicals. We discuss the dual role of phytochemicals in both cancer induction and suppression, emphasizing their capacity to generate ROS and regulate ncRNA expression. Furthermore, the review underscores the importance of nutritional interventions and antioxidant regulation in cancer chemoprevention and therapy, including the interconnected roles of oxidative stress, ncRNAs, and phytochemicals in cancer development and treatment, with a focus on dietary modulation as a strategic approach in oncology.


  • Theranostic Application of Nanomedicine in Neurodegenerative Diseases: Current and Future Perspectives

    by Garima, Khalid Imtiyaz, Pooja, Prachi Pannu, Anjali Sharma, Smriti Raina, Sugandh Kumar, Syed Tauqeer Anwer, Moshahid Alam Rizvi, Shailendra Kumar Sinha, et al.


  • Open Access

    Polydatin: A natural compound with multifaceted anticancer properties

    by Khalid Imtiyaz, Mohsin Shafi, Khalid Umar Fakhri, Laraib Uroog, Bushra Zeya, Syed Tauqeer Anwer, M Moshahid Alam Rizvi


  • Epigenetic Regulation of Breast Cancer

    by Umesh Kumar, Garima Rathi, Lakshit Sharma, Khalid Umar Fakhri, Anil Kumar Mavi, Jyoti Goyal, Sumit Kumar

    Breast cancer is a carcinoma of mammary glands, which starts off as abnormal proliferation of ductal cells. This could, then, become either benign tumours or metastatic carcinomas. It is one of the most common causes of deaths because of cancer, and is one of the most common types of cancer in women in the whole world. India along with the US and China accounts for one-third of the breast cancer burden. The breast cancer carcinogenesis is attributed to epigenetics, which is the study of the reversible changes in the phenotype without any change in the DNA sequence. Genes, which are concerned with proliferation, anti-apoptosis, invasion, and metastasis, have been seen undergoing epigenetic changes in breast cancer. Cancer can be caused either by global hypomethylation (causing activation of oncogenes and leading to chromosomal instability) or by locus-specific hypermethylation (causing repression of gene expression and genetic instability due to inactivation of DNA repair genes). Other epigenetic mechanisms involved in carcinogenesis are histone modification and nucleosomal remodeling.

  • Strategies to Suppress Tumor Angiogenesis and Metastasis, Overcome Multi-Drug Resistance in Cancer, Target Telomerase and Apoptosis Pathways

    by Mohd Aleem, Deepshikha Sharma, Siddhartha Dan, Pooja Gupta, Khalid Umar Fakhri, M. Moshahid Alam Rizvi

    Cancer has been a worldwide topic in the medical field for a very long time. As angiogenesis is essential for tumor growth and metastasis, controlling tumor-associated angiogenesis is a promising tactic in limiting cancer progression. In cancer patients, multidrug resistance (MDR) is most widely used phenomenon by which cancer acquired resistance to chemotherapy. This resistance to chemotherapy occurs due to the formation of insulated tumor microenvironment which remains a major hurdle in the cure of various types of cancer. The mechanisms that cause malignant growth of cells include cell cycle control, signal transduction pathways, apoptosis, telomere stability, and interaction with the extracellular matrix. This chapter focuses on current strategies to suppress tumor angiogenesis for cancer therapy, various mechanisms involved in the development of MDR in cancer cells, which in turn will help us to identify possible strategies to overcome these MDR mechanisms and a variety of procedures that involves targeting apoptotic and telomerase pathways to suppress tumor progression.

  • Apoptotic Pathway

    by Durdana Yasin, Zafaryab, Khalid Umar Fakhri, Shaheen Husain, Bushra Afzal, Neha Sami, Hemlata Hemlata, M. Moshahid Alam Rizvi, Tasneem Fatma

    Cancer is a major killer disease caused by uncontrolled growth and invasion of cells. Apoptosis is the cell's natural mechanism of death, which maintains tissue homeostasis. Any mutation that disturbs the apoptotic pathway leads to deregulated proliferation, resistance, and evasion of apoptosis. This evasion is one of the hallmarks of malignant developments. Apoptosis takes place via two distinct pathways i.e. the intrinsic and the extrinsic pathways. These pathways use cleaved caspases to execute apoptosis which in turn cleave many downstream proteins to kill the cells. They can also be inhibited through various means that include up-regulation of anti-apoptotic and down-regulation of pro-apoptotic factors. The authors here aim to impart a comprehensive understanding of the biochemical characteristics of these pathways that render scientists target these pathways and assess apoptosis restoring abilities of the novel drugs and natural products for cancer treatment.

  • Phytopharmaceuticals in Cancer Treatment

    by Khalid Umar Fakhri, Bader Saud Alotaibi, Sumit Kumar, Umesh Kumar, Subash C. Sonkar, Ankit Mathur, Zakia Kazim, Ahmad Perwez, Durdana Yasin, Bushra Zeya, et al.

    Several modern treatment procedures have been received to battle malignancy with the point of limiting lethality. Phytopharmaceuticals are auxiliary metabolites of plant origin which exclusively contain one or more substances as active ingredients or might be a blend of them. Analysts have excitedly attempted to diminish the lethality of current chemotherapeutic agents either by consolidating them with herbals or in utilizing herbals alone. Synergy is a procedure where a few substances participate to reach a consolidated impact that is more prominent than the entirety of their different impacts. It may be viewed as a characteristic straight technique that has developed ordinarily by nature to acquire more efficacies at a low cost. This chapter aims to present the fundamental mechanism of the activity of phytochemicals in combination therapy. This chapter additionally features the remarkable synergistic impacts of plant-drug cooperation with an emphasis on anticancer strategies.


  • Functional Mechanisms of Green Tea Polyphenols and Their Molecular Targets in Prevention of Multiple Cancers

    by Zubair Bin Hafeez, Khalid Umar Fakhri, Zafaryab, M. Moshahid Alam Rizvi

    Cancer is portrayed as a group of disease characterized by alteration in the normal regulation of cell growth by the successive acquisition of genetic, somatic, and epigenetic alteration. Synthetic drugs are single targets while natural products are multi-targeted to prevent cancer. NF-κB is persistently active in a number of disease states, including cancer, and therefore has a critical role in cancer development and progression. It also provides a mechanistic link between inflammation and cancer and is a major controlling factor resistant to apoptosis in both pre-neoplastic and malignant cells. Importantly, NF-kB and the signaling pathways that mediate its activation have become attractive targets for the development of new chemopreventive and chemotherapeutic approaches. Natural antioxidants have been shown to possess chemopreventive and chemotherapeutic potential via targeting NF-κB signaling, among which tea polyphenols have been studied extensively. In this chapter, the authors summarize the regulation of NF-κB pathway by green tea polyphenols in different cancer types.

  • Cancer Immunotherapy

    by Mohammad Raghibul Hasan, Bader Saud Alotaibi, Sultan F. Alnomasy, Khalid Umar Fakhri

    Cancer immunotherapy has become a powerful clinical strategy as well as an established pillar for the treatment of cancers to improving the prognosis of many cancer patients with a broad variety of solid tumors as well as blood cancers. The primary goals of immunotherapy are (a) to increase anti-tumor response, (b) decrease the immune suppression, and (c) to enhance the immunogenicity of tumors. This chapter aims to discuss the mechanism and different types of immunotherapies used for different cancers. It will also focus on recombinant products including immunostimulants, immunotoxins, antibodies, fusion proteins, engineered cytotoxic T cells, engineered immunocytokines, vaccines, checkpoint inhibitors, CAR T-cell therapy, and nanomedicine. Although immunotherapy has a rare side effect, it is not fully understood. The development of new strategies has been on the clinical trial to enhance the benefit of cancer patients to meet with challenges of limited efficacy and/or toxicity.